Vicarious Surgical Inc. (RBOT) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.12
↓-97% vs avg
5yr avg: 3.64
30Y Low0.5·High61.9
ROE
↓
-177.5%
↑-123% vs avg
5yr avg: -79.6%
30Y Low-178%·High5%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
RBOT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Vicarious Surgical Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $1M | $13M | $77M | $54M | $257M | $1.0B | $1.0B | — |
| Enterprise Value | $7M | $18M | $82M | $16M | $157M | $854M | $1.0B | — |
| P/E Ratio → | -0.02 | — | — | — | 50.08 | — | — | — |
| P/S Ratio | — | — | — | — | — | — | — | — |
| P/B Ratio | 0.12 | 1.31 | 1.66 | 0.55 | 2.32 | 12.35 | 61.94 | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
RBOT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | 29.28 | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
RBOT Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -177.5% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Net Profit Margin | — | — | — | — | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -177.5% | -177.5% | -87.4% | -68.0% | 5.3% | -70.5% | -79.3% | -59.6% |
| ROA | -115.0% | -115.0% | -67.4% | -54.6% | 3.2% | -35.3% | -75.4% | -56.9% |
| ROIC | -116.2% | -116.2% | -90.2% | -171.6% | — | — | -141.9% | — |
| ROCE | -134.6% | -134.6% | -77.1% | -66.0% | -52.1% | -39.7% | -79.4% | -62.1% |
RBOT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $5M ($8M total debt minus $3M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.79 | 0.79 | 0.30 | 0.15 | 0.14 | 0.02 | 0.01 | 0.01 |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.53 | 0.09 | -0.39 | -0.91 | -2.07 | -0.99 | -0.13 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | -2841.84 | 26.79 | -394.58 | -4328.33 | — |
RBOT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Vicarious Surgical Inc.'s current ratio of 2.97x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 13.87x to 2.97x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | 2.97 | 6.74 | 13.87 | 14.35 | 28.56 | 21.04 | 25.30 |
| Quick Ratio | 2.97 | 2.97 | 6.74 | 13.87 | 14.35 | 28.56 | 21.04 | 25.30 |
| Cash Ratio | 2.51 | 2.51 | 6.40 | 13.49 | 13.85 | 27.78 | 20.72 | 24.89 |
| Asset Turnover | — | — | — | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — |
RBOT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Vicarious Surgical Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 2.0% | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $6M | $6M | $5M | $4M | $3M | $3M | $5M |
Peer Comparison
Compare RBOT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 RBOTYou | $1M | -0.0 | — | — | — | — | -177.5% | -116.2% | — |
 ISRG | $143B | 51.2 | 38.7 | 57.5 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 MASI | $9B | -64.3 | 28.0 | 47.6 | 61.9% | 20.5% | -17.1% | 16.5% | 1.6 |
 SSYS | $744M | -6.7 | — | — | 47.0% | -10.7% | -12.7% | -5.8% | — |
 TMCI | $260M | -4.3 | — | — | 79.8% | -25.5% | -58.9% | -31.0% | — |
 SYK | $117B | 36.3 | 21.0 | 27.2 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 NVCR | $2B | -11.2 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 GMED | $11B | 20.2 | 17.1 | 18.1 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
 ABT | $153B | 11.5 | 16.0 | 24.0 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 BSX | $66B | 22.9 | 20.4 | 18.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
RBOT — Frequently Asked Questions
Quick answers to the most common questions about buying RBOT stock.
What is Vicarious Surgical Inc.'s P/E ratio?
Vicarious Surgical Inc.'s current P/E ratio is -0.0x. The historical average is 50.1x.
What is Vicarious Surgical Inc.'s ROE?
Vicarious Surgical Inc.'s return on equity (ROE) is -177.5%. The historical average is -76.7%.
Is RBOT stock overvalued?
Based on historical data, Vicarious Surgical Inc. is trading at a P/E of -0.0x. Compare with industry peers and growth rates for a complete picture.